Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
<p><strong>Background:</strong> Lopinavir–ritonavir has been proposed as a treatment for COVID-19 on the basis of in vitro activity, preclinical studies, and observational studies. Here, we report the results of a randomised trial to assess whether lopinavir–ritonavir improves outc...
| Autor principal: | |
|---|---|
| Altres autors: | |
| Format: | Journal article |
| Idioma: | English |
| Publicat: |
Elsevier
2020
|